|
AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
StreetInsider.com AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the … AstraZeneca Enters Companion Diagnostic Test Deal With Abbott |
View full post on asthma – Google News